Neurimmune Therapeutics Announces Advancement of Alzheimer’s Program into Preclinical Development

News   Aug 19, 2009

 
Neurimmune Therapeutics Announces Advancement of Alzheimer’s Program into Preclinical Development
 
 
 

RELATED ARTICLES

Dietary Fat Metabolism May Promote Metastasis

News

A new study has highlighted links between dietary fat and prostate cancer, suggesting a high-fat Western diet may encourage tumour metastasis.

READ MORE

Metrohm USA Opens Its New Headquarters in Florida

News

Metrohm USA welcomes its Tampa employees to their new North American headquarters in Riverview, Florida.

READ MORE

Synaptic Proteins May Be Starting Point for Dementia Treatment

News

A new study has identified key proteins, located at the brain's synaptic connections, which may be viable targets for dementia treatment.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE